Independent destination comparison for IVF abroad · Part of the ColombiaMedical.co network
ivfabroad.co
Home/Guides/Decisions
Decisions

Recurrent Implantation Failure: The Workup to Do Before Another Cycle Abroad

Several good embryos, no implantation. Before you book another cycle abroad, check the workup you are offered against ESHRE's 2023 recommendations and do the useful parts at home.

Updated October 31, 2026•10 min read•5 sources•ivfabroad.co editorial team

The short version

  • ESHRE defines RIF by your cumulative predicted chance of implantation (a 60% threshold), not by a fixed number of failed transfers.
  • The 2023 paper sorts 19 investigations and 13 interventions into recommended, can be considered, or not recommended for routine use.
  • Recommended steps are basic: lifestyle review and re-checking endometrial thickness. NK cell, uterine T cell and microbiome testing are not recommended.
  • Do most of the workup at home and send results, so a trip abroad is for treatment rather than testing.
  • If nothing is found and your predicted odds were good, the honest next question is often embryo quality and donor options, or a different clinic.
On this page (7)
  1. What ESHRE means by recurrent implantation failure
  2. How ESHRE grades the tests and treatments
  3. The RIF workup: what ESHRE recommends, allows and advises against
  4. What to do at home before another trip
  5. How to judge a clinic that offers a long test list
  6. When to change strategy instead of repeating the same cycle
  7. Questions to ask before your next cycle abroad

When several good embryos have been transferred and none implanted, the next clinic you contact abroad may answer with a long list of tests and add-on treatments. Some of them are worth doing. Many are not, and a few will cost more than another transfer.

The most useful yardstick is the European Society of Human Reproduction and Embryology (ESHRE) good practice paper on recurrent implantation failure (RIF), published in 2023. This guide walks through what it says, what you can do at home before booking another trip, and how to tell a careful workup from a padded one.

What ESHRE means by recurrent implantation failure

ESHRE treats RIF as something that only exists in the context of assisted reproduction. It describes the situation where embryos considered viable have been transferred, and they have failed to produce a positive pregnancy test often enough, for that specific patient, to justify looking for a cause or trying something different.1

The key word is individual. ESHRE did not set a fixed number of failed transfers. Instead, it recommends a threshold based on your cumulative predicted chance of implantation: once that predicted chance across your transfers has passed 60% and you still have not had an implantation, you should be counseled about further investigation or treatment.12

In practice, that predicted chance depends on things like your age when the eggs were collected, embryo stage and quality, whether the embryos had chromosome testing, and how many were transferred. Two people with three failed transfers each can be in very different places. One may have crossed the threshold; the other may simply have had expected bad luck.

Why this matters for travel

If a clinic labels you "RIF" after a set count of failures without estimating your predicted odds, it is using a simpler rule than the one ESHRE adopted. Ask how they reached the label before you agree to anything built on it.

How ESHRE grades the tests and treatments

The paper contains 19 recommendations on investigations and 13 on interventions. Each one sits in one of three categories: recommended, can be considered, or not recommended for routine use.1

60%cumulative predicted implantation chance used as the RIF threshold, ESHRE 2023
19recommendations on investigations, ESHRE 2023
13recommendations on interventions, ESHRE 2023

It helps to know how the paper was made. An ESHRE working group of eight members, with an independent chair and a statistics expert, drew on a literature search, an earlier survey of clinical practice and expert opinion. ESHRE members then commented on a draft online.1 ESHRE has published the report of that review round.3

That makes it a good practice paper, not a guideline built on large trials. For many RIF questions, the trials simply do not exist. The authors' central caution is that investigations and treatments should be limited to those "supported by a clear rationale and data indicating their likely benefit."4

The RIF workup: what ESHRE recommends, allows and advises against

The table below summarizes the investigations as they appear in the paper's text. Use it as a checklist against any test list a clinic sends you.

ESHRE 2023 RIF investigations by category
Test or stepESHRE categoryNotes
Review of lifestyle factors (smoking, weight, alcohol, caffeine)RecommendedBehavior can change, so it should be reviewed and optimized2
Re-assessment of endometrial thicknessRecommendedIf the lining stays thin, the paper advises reviewing the estrogen regimen4
Karyotyping of both partnersCan be consideredLow yield, but confirms there is no chromosomal rearrangement; genetic counseling and PGT are recommended if one is found2
3D transvaginal ultrasoundCan be consideredIf not already done during the original fertility workup2
HysteroscopyCan be consideredEspecially when ultrasound suggests a uterine anomaly2
HSG or other tubal imagingCan be consideredOnly if a hydrosalpinx is still in doubt after ultrasound2
Assessment for chronic endometritisCan be consideredAntibiotic treatment can be considered if it is diagnosed2
Antiphospholipid antibodiesCan be consideredEven without risk factors4
Thyroid functionCan be consideredListed as an option, not a routine requirement4
Late follicular and mid-luteal progesteroneCan be consideredRelevant to how the transfer cycle is prepared4
Tests of specific aspects of endometrial functionCan be consideredDistinct from commercial receptivity tests (next rows)2
Commercial endometrial receptivity testsNot recommended for routine useInsufficient data for routine use of any commercial test2
Vitamin D measurementNot recommended for routine useInsufficient data to measure or treat routinely2
Peripheral or uterine natural killer (NK) cell testingNot recommendedNeither blood nor uterine NK testing is recommended4
Uterine T lymphocyte assessmentNot recommended4
Uterine and vaginal microbiome profilingNot recommended4
MRI or diagnostic laparoscopySituationalOnly if new suspicion of a problem arises2

On treatments for a thin lining, the paper describes the evidence for platelet-rich plasma (PRP) and G-CSF as limited or conflicting, with more studies needed. Lipid infusions and steroids, sometimes offered for suspected immune causes, still need randomized trials.4

The intervention section rates 13 treatments on the same three-level scale. Before paying for any intervention, ask the clinic which ESHRE category it falls in. If they are recommending something outside routine use, ask them to explain in writing why your case is the exception.

What to do at home before another trip

Most of the "recommended" and "can be considered" items are ordinary tests: bloodwork, ultrasound, and in some cases hysteroscopy. Your local fertility specialist or gynecologist can usually arrange them. Doing them at home means the clinic abroad receives results rather than a reason to schedule a diagnostic-only visit.

  1. Collect every transfer record. For each attempt: date, embryo stage and grade, whether it was chromosome-tested, how many were transferred, endometrial thickness, medications and protocol, and any notes on a difficult transfer. Our guide to sending fertility records to an overseas clinic covers formats and translation.
  2. Ask for an estimate of your cumulative predicted chance. A reproductive endocrinologist can tell you whether your history plausibly crosses the 60% threshold ESHRE uses, or whether another transfer of similar embryos is still reasonable.
  3. Cover the recommended steps first. A lifestyle review and a fresh look at endometrial thickness and the estrogen protocol cost little and are in ESHRE's top category.
  4. Add targeted "can be considered" tests only with a reason. For example, hysteroscopy if an ultrasound suggests a polyp or anomaly, or tubal imaging if a hydrosalpinx is suspected.
  5. Send results ahead and ask for a written plan. A second opinion from another clinic is worth having at this stage; see our piece on getting several international perspectives.
When to get care now

Severe pelvic pain, heavy bleeding, fever or fainting after any transfer or procedure needs prompt in-person care where you are. Do not wait for an email reply from a clinic abroad.

How to judge a clinic that offers a long test list

A long list is not automatically a bad sign. Some clinics send a menu and let you choose. What matters is whether the list is tied to your history and to the evidence, and whether each item is priced separately.

A workup that tracks ESHRE

  • Starts by estimating your predicted chance and whether RIF applies
  • Prioritizes lifestyle, endometrial thickness and the transfer protocol
  • Adds imaging or karyotyping for a stated reason
  • Prices each test and treatment as its own line
  • Explains in writing any step outside routine use

A workup that should prompt questions

  • Applies the RIF label from a failure count alone
  • Bundles NK cell, T cell or microbiome panels
  • Sells a receptivity test as standard for everyone
  • Proposes immune treatments based on those panels
  • Quotes one "RIF package" price with no breakdown

The UK regulator, the HFEA, keeps a public page rating the evidence for common treatment add-ons, which is a useful second check when a clinic outside the UK proposes extras.5 Bundled extras are one of the main ways quotes grow; our breakdown of hidden fees in IVF abroad shows where they tend to appear. If chromosome testing of embryos is part of the proposal, read what to verify about PGT-A abroad first.

When to change strategy instead of repeating the same cycle

A workup sometimes finds something specific. More often it does not, and the honest conclusion is that the limiting factor is likely the embryos, the odds, or both. Either way, the result should change the plan.

Workup findings and possible next steps
FindingWhat ESHRE saysPractical next step
Chromosomal rearrangement in a partnerGenetic counseling and PGT recommended2Choose a clinic with a genetics service and check PGT is legal in that country
Polyp, septum or other uterine findingHysteroscopy can be considered2Treat first, often at home, then plan the transfer
Suspected hydrosalpinxTubal imaging can be considered if in doubt2Get a surgical opinion before another transfer
Chronic endometritis diagnosedAntibiotics can be considered2Complete treatment before traveling
Lining stays thinRe-assess thickness; review estrogen regimen4Ask about protocol changes; be cautious about PRP or G-CSF
Nothing found; predicted chance passed 60%Counsel about options1Discuss whether embryo quality is the limit and whether donor options fit

If egg age or embryo quality is the likely limit, donor eggs are the change that most often comes up. Our donor egg IVF abroad guide covers how programs work, and Spain vs Czech Republic for donor eggs compares two common destinations. Donor embryos are another route; see embryo and gamete donation compared internationally.

Sometimes the right change is the clinic itself. If your first destination did not explain its reasoning or share full records, our guide to choosing a second destination after a failed attempt sets out what to look for.

Questions to ask before your next cycle abroad

  • Based on my records, what do you estimate my cumulative predicted chance of implantation has been so far?
  • Do you consider this recurrent implantation failure under ESHRE's 2023 definition, and why?
  • Which of the tests you propose are in ESHRE's "recommended" or "can be considered" categories?
  • For anything not recommended for routine use, what is the specific reason in my case?
  • Can I do these tests at home and send the results instead?
  • What will you change about the embryo, the lining or the protocol for the next transfer?
  • What is the itemized price of each test and treatment, and what happens if results are normal?
  • If this transfer fails, what would you recommend next, and at what point would you raise donor options?

When you have a written plan and itemized prices from more than one clinic, you can request a quote to compare destinations side by side. Our list of questions to ask any IVF clinic covers the broader checks on lab, staff and success reporting.

Repeated failed transfers take a real toll. Whatever the workup shows, it is reasonable to pause, get support, and make the next decision with your own doctor rather than on a clinic's timeline.

Compare clinics on their plan, not just their price

Send us your transfer history and the workup each clinic proposes, and we will help you line up written plans and itemized quotes from more than one destination.

Quick answers

How many failed embryo transfers count as recurrent implantation failure?

ESHRE's 2023 good practice paper does not use a fixed number. It recommends counseling about investigation or treatment once your cumulative predicted chance of implantation has passed 60% without an implantation. That estimate depends on factors such as egg age, embryo quality and whether embryos were chromosome-tested.

Does ESHRE recommend natural killer (NK) cell testing for implantation failure?

No. The paper states that neither peripheral blood nor uterine NK cell testing is recommended, and uterine T lymphocyte assessment is not recommended either. It notes that lipid infusions and steroids proposed for suspected immune causes still need randomized trials.

Should I get an endometrial receptivity test after failed transfers?

ESHRE found insufficient data to recommend routine use of any commercial endometrial receptivity test. It does say testing specific aspects of endometrial function can be considered. If a clinic proposes a commercial test, ask why it applies to your case and what it costs as a separate line.

Which RIF tests can I do at home before traveling?

Most of them. A lifestyle review, endometrial thickness checks, ultrasound, bloodwork such as thyroid function or antiphospholipid antibodies, karyotyping and hysteroscopy are routinely available through local specialists. Sending results ahead lets the clinic abroad plan treatment instead of a diagnostic visit.

When should I consider donor eggs after implantation failure?

When a workup finds no treatable cause and egg age or embryo quality is the likely limit, donor eggs often come up. That decision belongs with your fertility specialist, ideally after an estimate of your predicted odds with your own eggs.

Sources

  1. Human Reproduction Open / PubMed: ESHRE good practice recommendations on recurrent implantation failure (abstract, PMID 37332387). pubmed.ncbi.nlm.nih.gov
  2. Human Reproduction Open, 2023(3):hoad023: ESHRE good practice recommendations on recurrent implantation failure (full text). academic.oup.com
  3. ESHRE: Review report: ESHRE good practice recommendations on RIF. ESHRE.EU
  4. Europe PMC: ESHRE good practice recommendations on recurrent implantation failure (full text, PMC10270320). ebi.ac.uk
  5. Human Fertilisation and Embryology Authority (HFEA): Treatment add-ons. hfea.gov.uk

Medical disclaimer: This article is educational content only — not medical advice, and not a substitute for consultation with a licensed reproductive endocrinologist. Success rates cited come from published registries and studies that vary by age, diagnosis and laboratory; no outcome can be guaranteed for any individual. All cost figures are published ranges, not quotes — confirm current pricing, physician credentials and legal requirements directly with any clinic and, where relevant, a qualified attorney.

The other half of the decision

This site covers where — destinations, laws, costs and logistics. For what — protocols, medications, add-ons and what the evidence says about treatment itself — our sister site covers the science.